Keyword Connections

combination therapy

Journals

16

1 ACS applied materials & interfaces

2 Nanomaterials (Basel, Switzerland)

3 international journal of nanomedicine

4 pakistan journal of pharmaceutical sciences

5 Theranostics

6 Chemical communications (Cambridge, England)

7 colloids and surfaces b, biointerfaces

8 Biomacromolecules

9 bioconjugate chemistry

10 Biochemical and biophysical research communications

11 journal of cancer research and therapeutics

12 drug development and industrial pharmacy

13 journal of materials chemistry b

14 Photodiagnosis and photodynamic therapy

15 Trends in cancer

16 the journal of infection

Research Groups

0

No Research Group Connected

Bibliographies

23

1 Co-delivery of doxorubicin and TRAIL plasmid by modified PAMAM dendrimer in colon cancer cells, and evaluation.

2 Light-controllable systems based on TiO-ZIF-8 composites for targeted drug release: communicating with tumour cells.

3 Ultrasensitive photoelectrochemical microRNA biosensor based on doxorubicin sensitized graphitic carbon nitride assisted by a target-activated enzyme-free DNA walker.

4 SHORT COMMUNICATION-Anticancer activity of Ziziphus mauritiana roots against human breast cancer cell line.

5 The synergistic cytotoxic effects of doxorubicin and extract on human breast cancer cell line T47-D.

6 Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma.

7 Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.

8 Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.

9 Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.

10 Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.

11 Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study.

12 mechanisms of antibiotic resistance

13 novel polymyxin combination with antineoplastic mitotane improved the bacterial killing against polymyxin-resistant multidrug-resistant gram-negative pathogens

14 pharmacological modulation of anti-tumor immunity induced by oncolytic viruses

15 emerging therapies for childhood polycystic kidney disease

16 a new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

17 a better antiviral efficacy found in nucleos(t)ide analog (na) combinations with interferon therapy than na monotherapy for hbeag positive chronic hepatitis b: a meta-analysis

18 synergistic effect of haloduracin and chloramphenicol against clinically important gram-positive bacteria

19 self-assembled albumin nanoparticles for combination therapy in prostate cancer

20 Transferrin-Modified Nanoliposome Codelivery Strategies for Enhancing the Cancer Therapy

21 Dual drug delivery system of RAPTA-C and paclitaxel based on fructose coated nanoparticles for metastatic cancer treatment.

22 Drug independence and the curability of cancer by combination chemotherapy.

23 Conversion treatment for advanced intrahepatic cholangiocarcinoma: Opportunities and challenges.